WallStSmart

Cencora Inc. (COR)vsSynergy CHC Corp. Common Stock (SNYR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cencora Inc. generates 941814% more annual revenue ($325.78B vs $34.59M). SNYR leads profitability with a 7.5% profit margin vs 0.5%. SNYR trades at a lower P/E of 4.2x. COR earns a higher WallStSmart Score of 62/100 (C+).

COR

Buy

62

out of 100

Grade: C+

Growth: 6.7Profit: 6.0Value: 7.3Quality: 5.0

SNYR

Hold

45

out of 100

Grade: D

Growth: 4.3Profit: 6.0Value: 7.0Quality: 7.0
Piotroski: 4/9Altman Z: -0.45
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CORSignificantly Overvalued (-43.9%)

Margin of Safety

-43.9%

Fair Value

$254.20

Current Price

$327.27

$73.07 premium

UndervaluedFair: $254.20Overvalued
SNYRUndervalued (+13.2%)

Margin of Safety

+13.2%

Fair Value

$1.90

Current Price

$1.17

$0.73 discount

UndervaluedFair: $1.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

COR3 strengths · Avg: 9.0/10
Return on EquityProfitability
133.5%10/10

Every $100 of equity generates 134 in profit

Market CapQuality
$63.59B9/10

Large-cap with strong market position

PEG RatioValuation
0.788/10

Growing faster than its price suggests

SNYR2 strengths · Avg: 10.0/10
P/E RatioValuation
4.2x10/10

Attractively priced relative to earnings

Debt/EquityHealth
-3.0410/10

Conservative balance sheet, low leverage

Areas to Watch

COR4 concerns · Avg: 3.0/10
P/E RatioValuation
39.2x4/10

Premium valuation, high expectations priced in

Profit MarginProfitability
0.5%3/10

0.5% margin — thin

Operating MarginProfitability
1.2%3/10

Operating margin of 1.2%

Price/BookValuation
33.4x2/10

Trading at 33.4x book value

SNYR4 concerns · Avg: 2.5/10
Market CapQuality
$13.16M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
7.5%3/10

7.5% margin — thin

Return on EquityProfitability
-3.6%2/10

ROE of -3.6% — below average capital efficiency

EPS GrowthGrowth
-90.6%2/10

Earnings declined 90.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : COR

The strongest argument for COR centers on Return on Equity, Market Cap, PEG Ratio. PEG of 0.78 suggests the stock is reasonably priced for its growth.

Bull Case : SNYR

The strongest argument for SNYR centers on P/E Ratio, Debt/Equity. Revenue growth of 12.4% demonstrates continued momentum.

Bear Case : COR

The primary concerns for COR are P/E Ratio, Profit Margin, Operating Margin. Thin 0.5% margins leave little buffer for downturns.

Bear Case : SNYR

The primary concerns for SNYR are Market Cap, Profit Margin, Return on Equity.

Key Dynamics to Monitor

SNYR carries more volatility with a beta of 1.27 — expect wider price swings.

SNYR is growing revenue faster at 12.4% — sustainability is the question.

SNYR generates stronger free cash flow (-2M), providing more financial flexibility.

Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

COR scores higher overall (62/100 vs 45/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cencora Inc.

HEALTHCARE · MEDICAL DISTRIBUTION · USA

CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.

Synergy CHC Corp. Common Stock

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Synergy CHC Corp. The company is headquartered in Westbrook, Maine.

Want to dig deeper into these stocks?